Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 4, Avril 2003
Page(s) 443 - 452
Section M/S Revues
DOI https://doi.org/10.1051/medsci/2003194443
Publié en ligne 15 avril 2003
  1. Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 1998; 77: 31–7.
  2. Steinmann B, Royce PM, Supeti-Furga A. the Elhersdanlos syndrome. In: Royce PM, Steinman B, eds. Connective tissue and its heritable disorders. New York: Wiley-Liss, 1993 : 351–408.
  3. Mao JR, Bristow J. The Ehlers-Danlos syndrome: on beyond collagens. J Clin Invest 2001; 107: 1063–9.
  4. Fichard A, Kleman JP, Ruggiero F. Another look at collagen V and XI molecules. Matrix Biol 1995; 14: 515–31.
  5. Birk DE. Type V collagen: heterotypic type I/V collagen interactions in the regulation of fibril assembly. Micron 2001; 32: 223–37.
  6. Erickson HP. Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions. Curr Opin Cell Biol 1993; 5: 869–76.
  7. Nicholls AC, McCarron SM, Narcisi P, Pope FM. Molecular abnormalities of type V collagen in the Ehlers- Danlos syndrome. Am J Hum Genet 1994; 62: 523–8.
  8. Michalickova K, Susic M, Willing MC, Wenstrup RJ, Cole WG. Mutations of the α 2(V) chain of type V collagen impair matrix assembly and produce Ehlers-Danlos syndrome type I. Hum Mol Genet 1998; 7: 249–55.
  9. Richards AJ, Martin S, Nicholls AC, Harrison JB, Pope FM, Burrows NP. A single base mutation in COL5A2 causes Ehlers- Danlos syndrome type II. J Med Genet 1998; 35: 846–8.
  10. Toriello HV, Glover TV, Takahara K, et al. A translocation interrupts the COL5A1 gene in a patient with Ehlers-Danlos syndrome and hypomelanosis of Ito. Nat Genet 1996; 13: 361–5
  11. Wenstrup RJ, Langland GT, Willing MC, D’Souza VN, Cole WG. A splice junction mutation in the region of COL5A1 that codes for the carboxyl propeptide of pro- α1(V) chains results in gravis form of Ehlers- Danlos syndrome (type I). Hum Mol Genet 1996; 5: 1733–6.
  12. Nicholls AC, Oliver JE, McCarron S, Harrison JB, Greenspan DS, Pope FM. An exon skipping mutation of a type V collagen gene (COL5A1) in Ehlers-Danlos syndrome. J Med Genet 1996; 33: 940–6.
  13. De Paepe A, Nuytinck L, Hausser I, Anton- Lamprecht I, Naeyaert JM. Mutations in the COL5A1 gene are causal in the Ehlers-Danlos syndromes I and II. Am J Hum Genet 1997; 60: 547–54
  14. Burrows NP, Nicholls AC, Richards AJ, et al. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet 1998; 63: 390–8.
  15. Giunta C, Steinmann B. Characterization of 11 new mutations in COL5A1 of individuals with Ehlers- Danlos syndrome type IV: preliminary comparison of RNase cleavage, EMC and DHPLC assays. Hum Mutat 2000; 16: 176–7.
  16. Schwarze U, Atkinson M, Hoffman GG, Greenspan DS, Byers PH. Null alleles of the COL5A1 gene of type V collagen are a cause of the classical forms of Ehlers- Danlos syndrome (types I and II). Am J Hum Genet 2000; 66: 1757–65.
  17. Bouma P, Cabral WA, Cole WG, Marini JC. COL5A1 exon 14 splice acceptor mutation causes a functional null allele, haploinsufficiency of α1(V) and abnormal heterotypic interstitial fibrils in Ehlers-Danlos syndrome II. J Biol Chem 2001; 276: 13356–64.
  18. Imamura Y, Scott IC, Greenspan DS. The pro- α3(V) collagen chain. Complete primary structure, expression domains in adult and developing tissues, and comparison to the structures and expression domains of the other types V and XI procollagen chains. J Biol Chem 2000; 275: 8749–59.
  19. Chernousov MA, Rothblum K, Tyler WA, Stahl RC, Carey DJ. Schwann cells synthesize type V collagen that contains a novel α4 chain. Molecular cloning, biochemical characterization, and high affinity heparin binding of α4(V) collagen. J Biol Chem 2000; 275: 28208–15.
  20. Nuytinck L, Freund M, Lagae L, Pierard GE, Hermanns-Le T, De Paepe A. Classical Ehlers-Danlos syndrome caused by a mutation in type I collagen. Am J Hum Genet 2000; 66: 1398–402.
  21. Burch GH, Gong Y, Liu W, et al. Tenascin-X deficiency is associated with Ehlers- Danlos syndrome. Nat Genet 1997; 17: 104–8.
  22. Schalkwijk J, Zweers MC, Steijlen PM, et al. A recessive form of the Ehlers-Danlos syndrome caused by tenascin-X deficiency. N Engl J Med 2001; 345: 1167–75.
  23. Lohler J, Timpl R, Jaenisch R. Embryonic lethal mutation in mouse collagen I gene causes rupture of blood vessels and is associated with erythropoietic and mesenchymal cell death. Cell 1984; 38: 597–607.
  24. Chipman SD, Sweet HO, Davisson MT, et al. Defective proa2(I) collagen synthesis in a recessive mutation in mice: a model of human osteogenesis imperfecta. Proc Natl Acad Sci USA 1993; 90: 1705–5.
  25. Liu X, Wu H, Byrne M, Krane S, Jaenisch R. Type III collagen is crucial for collagen I fibrillogenesis and for normal cardiovascular development. Proc Natl Acad Sci USA 1997; 94: 1852–6.
  26. Andrikopoulos K, Liu X, Keene DR, Jaenisch R, Ramirez F. Targeted mutation in the col5a2 gene reveals a regulatory role for type V collagen during matrix assembly. Nat Genet 1995; 9 :31–6.
  27. Mao JR, Taylor G, Dean WB, et al. Tenascin-X deficiency mimics Ehlers-Danlos syndrome in mice through alteration of collagen deposition. Nat Genet 2002; 30: 421–5.
  28. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H. Lumican regulates collagen fibril assembly: skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998; 141: 1277–86.
  29. Svensson L, Aszodi A., Reinholt FP, Fassler R, Heinegard D, Oldberg A. Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon J Biol Chem 1999; 274: 9636–47.
  30. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV. Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997; 136: 729–43.
  31. Fushimi H, Kameyama M, Shinkai H. Deficiency of the core proteins of dermatan sulphate proteoglycans in a variant form of Ehlers- Danlos syndrome. J Intern Med 1989; 226: 409–16
  32. Quentin E, Gladen A, Roden L, Kresse H. A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci USA 1990; 87: 1342–6.
  33. Kyriakides TR, Zhu YH, Smith LT, et al. Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol 1998; 140: 419–30.
  34. Bradshaw AD, Sage EH. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J Clin Invest 2001; 107: 1049–54.
  35. Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE. Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol 2000; 151: 779–88.
  36. Fichard A, Tillet E, Delacoux F, Garrone R, Ruggiero F. Human recombinant α1(V) collagen chain. Homotrimeric assembly and subsequent processing. J Biol Chem 1997; 272: 30083–7.
  37. Delacoux F, Fichard A, Geourjon C, Garrone R, Ruggiero F. Molecular features of the collagen V heparin binding site. J Biol Chem 1998; 273: 15069–76.
  38. Chanut-Delalande H, Fichard A, Bernocco S, Garrone R, Hulmes DJ, Ruggiero F. Control of heterotypic fibril formation by collagen V is determined by chain stoichiometry. J Biol Chem 2001; 276: 24352–9.
  39. Scott JE, Thomlinson AM. The structure of interfibrillar proteoglycan bridges (shape modules) in extracellular matrix of fibrous connective tissues and their stability in various chemical environments. J Anat 1998; 192: 391–405.
  40. Mundlos S, Chan D, McGill J, Bateman JF. An α1(II) Gly913 to Cys substitution prevents the matrix incorporation of type II collagen which is replaced with type I and III collagens in cartilage from a patient with hypochondrogenesis. Am J Med Genet 1996; 63: 129–36.
  41. Ruggiero F, Comte J, Cabanas C, Garrone R. Structural requirements for α1β1 and α2β1 integrin mediated cell adhesion to collagen V. J Cell Sci 1996; 109: 1865–74.
  42. Tillet E, Ruggiero F, Nishiyama A, Stallcup WB. The membrane-spanning proteoglycan NG2 binds to collagens V and VI through the central nonglobular domain of its core protein. J Biol Chem 1997; 272: 10769–76.
  43. Vogel W, Brakebusch C, Fassler R, Alves F, Ruggiero F, Pawson T. Discoidin domain receptor 1 is activated independently of β(1) integrin. J Biol Chem 2000; 275: 5779–84.
  44. De Paepe A. The Ehlers- Danlos syndrome: a heritable collagen disorder as cause of bleeding. Thromb Haemost 1996; 75: 379–86.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.